CAR T cells in solid tumors: challenges and opportunities F Marofi, R Motavalli, VA Safonov, L Thangavelu, AV Yumashev, ... Stem cell research & therapy 12, 1-16, 2021 | 457 | 2021 |
Mesenchymal stem/stromal cells as a valuable source for the treatment of immune-mediated disorders A Markov, L Thangavelu, S Aravindhan, AO Zekiy, M Jarahian, ... Stem cell research & therapy 12, 1-30, 2021 | 341 | 2021 |
Nanoparticulate drug-delivery systems: an overview D Thassu, Y Pathak, M Deleers Nanoparticulate drug delivery systems, 1-31, 2007 | 318 | 2007 |
A paradigm shift in cell-free approach: the emerging role of MSCs-derived exosomes in regenerative medicine S Moghadasi, M Elveny, HS Rahman, W Suksatan, AT Jalil, ... Journal of translational medicine 19, 1-21, 2021 | 243 | 2021 |
Drug delivery nanoparticles formulation and characterization Y Pathak, D Thassu Drugs and Pharmaceutical Science Series. informa healthcare USA 67, 1-30, 2009 | 210 | 2009 |
Novel CAR T therapy is a ray of hope in the treatment of seriously ill AML patients F Marofi, HS Rahman, ZMJ Al-Obaidi, AT Jalil, WK Abdelbasset, ... Stem Cell Research & Therapy 12, 1-23, 2021 | 183 | 2021 |
Polyacrylate (Eudragit retard) microspheres for oral controlled release of nifedipine. I. Formulation design and process optimization A Barkai, YV Pathak, S Benita Drug Development and Industrial Pharmacy 16 (13), 2057-2075, 1990 | 166 | 1990 |
Ocular drug delivery: impact of in vitro cell culture models A Solanki, S Desai, A Grover, A Hirani, Y Pathak, V Sutariya Nano-Biomaterials For Ophthalmic Drug Delivery, 483-494, 2016 | 155 | 2016 |
Surface modification of nanoparticles for targeted drug delivery P Patel, A Hanini, A Shah, D Patel, S Patel, P Bhatt, YV Pathak Surface modification of nanoparticles for targeted drug delivery, 19-31, 2019 | 113 | 2019 |
Targeting nanoparticles as drug delivery systems for cancer treatment K Subramani, H Hosseinkhani, A Khraisat, M Hosseinkhani, Y Pathak Current Nanoscience 5 (2), 135-140, 2009 | 107 | 2009 |
Introduction to artificial neural network (ANN) as a predictive tool for drug design, discovery, delivery, and disposition: Basic concepts and modeling M Puri, A Solanki, T Padawer, SM Tipparaju, WA Moreno, Y Pathak Artificial neural network for drug design, delivery and disposition, 3-13, 2016 | 81 | 2016 |
Brain-targeted delivery of docetaxel by glutathione-coated nanoparticles for brain cancer A Grover, A Hirani, Y Pathak, V Sutariya AAPS PharmSciTech 15, 1562-1568, 2014 | 76 | 2014 |
Artificial neural network for drug design, delivery and disposition M Puri, Y Pathak, VK Sutariya, S Tipparaju, W Moreno Academic Press, 2015 | 73 | 2015 |
Artificial neural network in drug delivery and pharmaceutical research V Sutariya, A Groshev, P Sadana, D Bhatia, Y Pathak The Open Bioinformatics Journal 7 (1), 2013 | 67 | 2013 |
Modifying drug release in suspensions of ionic resin systems YV Pathak, RL McMahen, M Tengler US Patent 8,313,770, 2012 | 63 | 2012 |
Degradation of materials in the biological environment AJ COURY, RJ LEVY, CR MCMILLIN, Y PATHAK, BD RATNER, ... Biomaterials science, 243-281, 1996 | 63 | 1996 |
Triamcinolone acetonide nanoparticles incorporated in thermoreversible gels for age-related macular degeneration A Hirani, A Grover, YW Lee, Y Pathak, V Sutariya Pharmaceutical development and technology 21 (1), 61-67, 2016 | 62 | 2016 |
An in vitro Assessment of Thermo-Reversible Gel Formulation Containing Sunitinib Nanoparticles for Neovascular Age-Related Macular Degeneration P Bhatt, P Narvekar, R Lalani, MB Chougule, Y Pathak, V Sutariya AAPS PharmSciTech 20, 1-14, 2019 | 55 | 2019 |
Prevention of calcification of glutaraldehyde pretreated bovine pericardium through controlled release polymeric implants: studies of Fe3+, Al3+, protamine sulphate and levamisole YV Pathak, J Boyd, RJ Levy, FJ Schoen Biomaterials 11 (9), 718-723, 1990 | 54 | 1990 |
Study of rosin and rosin esters as coating materials YV Pathak, RL Nikore, AK Dorle Int. J. Pharm 24 (2-3), 351-354, 1985 | 53 | 1985 |